Seeking Alpha
22 Sept 2026, 19:29 UTC · 1h ago
Viking Therapeutics, Inc. (VKTX) Discusses Top Line Data from VK2735 Maintenance Study in Obesity and Type 2 Diabetes Transcript
Verdict
Headline leans bullish. We score VKTX +0.60.
Score confirms the headline.
- Headline says
Leans bullish
From its wording — no explicit rating
- Expected · VKTX
+0.60strongly bullish

